Does OLAPARIB Cause Pancytopenia? 282 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 282 reports of Pancytopenia have been filed in association with OLAPARIB (Lynparza). This represents 1.5% of all adverse event reports for OLAPARIB.
282
Reports of Pancytopenia with OLAPARIB
1.5%
of all OLAPARIB reports
35
Deaths
130
Hospitalizations
How Dangerous Is Pancytopenia From OLAPARIB?
Of the 282 reports, 35 (12.4%) resulted in death, 130 (46.1%) required hospitalization, and 42 (14.9%) were considered life-threatening.
Is Pancytopenia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OLAPARIB. However, 282 reports have been filed with the FAERS database.
What Other Side Effects Does OLAPARIB Cause?
Death (4,378)
Malignant neoplasm progression (1,862)
Nausea (1,582)
Anaemia (1,455)
Fatigue (1,437)
Off label use (777)
Vomiting (642)
Drug ineffective (563)
Diarrhoea (514)
Asthenia (491)
What Other Drugs Cause Pancytopenia?
METHOTREXATE (5,377)
CYCLOPHOSPHAMIDE (3,351)
CARBOPLATIN (2,910)
RITUXIMAB (2,400)
LENALIDOMIDE (2,259)
DOXORUBICIN (2,212)
VINCRISTINE (2,180)
ETOPOSIDE (2,129)
DEXAMETHASONE (2,053)
PREDNISONE (1,743)
Which OLAPARIB Alternatives Have Lower Pancytopenia Risk?
OLAPARIB vs OLARATUMAB
OLAPARIB vs OLECLUMAB
OLAPARIB vs OLIVE OIL\SOYBEAN OIL
OLAPARIB vs OLMESARTAN
OLAPARIB vs OLMESARTAN MEDOXOMIL